| Year |
Citation |
Score |
| 2023 |
Hogwood J, Gray E, Mulloy B. Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment. Pharmaceuticals (Basel, Switzerland). 16. PMID 37259415 DOI: 10.3390/ph16020271 |
0.312 |
|
| 2023 |
Hogwood J, Mulloy B, Lever R, Gray E, Page CP. Pharmacology of Heparin and Related Drugs: An Update. Pharmacological Reviews. 75: 328-379. PMID 36792365 DOI: 10.1124/pharmrev.122.000684 |
0.513 |
|
| 2020 |
Tree JA, Turnbull JE, Buttigieg KR, Elmore MJ, Coombes N, Hogwood J, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen YH, Zhang Y, Spalluto CM, Staples KJ, Yates EA, et al. Unfractionated heparin inhibits live wild-type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. British Journal of Pharmacology. PMID 33125711 DOI: 10.1111/bph.15304 |
0.402 |
|
| 2020 |
Hogwood J, Pitchford S, Mulloy B, Page C, Gray E. Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. Plos One. 15: e0233644. PMID 32469940 DOI: 10.1371/Journal.Pone.0233644 |
0.504 |
|
| 2019 |
Thelwell C, Hogwood J, Daniels S, Rigsby P. A new WHO Reference Reagent for Activated Blood Coagulation Factor X (FXa), Human (15/102). Journal of Thrombosis and Haemostasis : Jth. PMID 31461800 DOI: 10.1111/Jth.14623 |
0.317 |
|
| 2019 |
Taylor SL, Hogwood J, Guo W, Yates EA, Turnbull JE. By-Products of Heparin Production Provide a Diverse Source of Heparin-like and Heparan Sulfate Glycosaminoglycans. Scientific Reports. 9: 2679. PMID 30804383 DOI: 10.1038/S41598-019-39093-6 |
0.314 |
|
| 2018 |
Hogwood J, Naggi A, Torri G, Page C, Rigsby P, Mulloy B, Gray E. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system. Plos One. 13: e0193482. PMID 29494632 DOI: 10.1371/Journal.Pone.0193482 |
0.514 |
|
| 2017 |
Hogwood J, Mulloy B, Gray E. Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate. Pharmaceuticals (Basel, Switzerland). 10. PMID 28671597 DOI: 10.3390/Ph10030059 |
0.451 |
|
| 2016 |
Lever R, Smailbegovic A, Riffo-Vasquez Y, Gray E, Hogwood J, Francis SM, Richardson NV, Page CP, Mulloy B. Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: Insights into the physiological role of endogenous heparin. Pulmonary Pharmacology & Therapeutics. PMID 27816772 DOI: 10.1016/J.Pupt.2016.11.002 |
0.471 |
|
| 2016 |
Thomson D, Moss C, Venkatasamy R, Panagos CG, Robinson J, Bavington CD, Hogwood J, Mulloy B, Uhrín D, Spina D, Page CP. Structural characterization and anti-inflammatory activity of two novel polysaccharides from the sea squirt, ascadellia aspersa. Pulmonary Pharmacology & Therapeutics. PMID 27220632 DOI: 10.1016/j.pupt.2016.05.001 |
0.429 |
|
| 2016 |
Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of Heparin and Related Drugs. Pharmacological Reviews. 68: 76-141. PMID 26672027 DOI: 10.1124/Pr.115.011247 |
0.532 |
|
| 2015 |
Longstaff C, Hogwood J, Gray E, Komorowicz E, Varjú I, Varga Z, Kolev K. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. Thrombosis and Haemostasis. 115. PMID 26632486 DOI: 10.1160/Th15-03-0214 |
0.342 |
|
| 2015 |
Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of Heparin and Related Drugs Pharmacological Reviews. 68: 76-141. DOI: 10.1124/pr.115.011247 |
0.374 |
|
| 2014 |
Panagos CG, Thomson DS, Moss C, Hughes AD, Kelly MS, Liu Y, Chai W, Venkatasamy R, Spina D, Page CP, Hogwood J, Woods RJ, Mulloy B, Bavington CD, UhrÃn D. Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity. The Journal of Biological Chemistry. 289: 28284-98. PMID 25147180 DOI: 10.1074/Jbc.M114.572297 |
0.521 |
|
| 2014 |
Wilmot HV, Hogwood J, Gray E. Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays. Haemophilia. 20: 891-897. PMID 24800651 DOI: 10.1111/Hae.12449 |
0.33 |
|
| 2012 |
Gray E, Hogwood J, Mulloy B. The anticoagulant and antithrombotic mechanisms of heparin. Handbook of Experimental Pharmacology. 43-61. PMID 22566220 DOI: 10.1007/978-3-642-23056-1_3 |
0.391 |
|
| 2011 |
Schroeder M, Hogwood J, Gray E, Mulloy B, Hackett AM, Johansen KB. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components. Analytical and Bioanalytical Chemistry. 399: 763-71. PMID 20922518 DOI: 10.1007/S00216-010-4220-8 |
0.348 |
|
| 2010 |
Mulloy B, Hogwood J, Gray E. Assays and reference materials for current and future applications of heparins Biologicals. 38: 459-466. DOI: 10.1016/J.Biologicals.2010.02.010 |
0.44 |
|
| 2006 |
Garner SF, Jones CI, Angenent W, Bernard A, Carr P, Hogwood J, Rankin A, Stephens J, Tom BD, Walton J, Dudbridge F, Ouwehand WH, Goodall AH. SI09 Analysing Platelet Function in Blood Donors: Selection of Subjects for Functional Genetic Studies Transfusion Medicine. 16: 7-7. DOI: 10.1111/J.1365-3148.2006.00693_14.X |
0.334 |
|
| Show low-probability matches. |